Senti Biosciences Inc.

NASDAQ:SNTI   3:00:14 PM EDT
2.00
+0.03 (+1.52%)
Earnings Announcements

Senti Bio Reports Third Quarter Results

Published: 11/10/2022 13:23 GMT
Senti Biosciences Inc. (SNTI) - Senti Bio Reports Third Quarter Financial Results and Pipeline Updates.
Senti Biosciences Inc - Cash Position of $114.9 Million As of September 30, 2022; Maintain Expectation of Cash Runway Into 2024.
Senti Biosciences Inc - Senti-202 on Track for Ind Filing in 2023.
Senti Biosciences Inc - Qtrly Loss per Share $0.38.
Revenue is expected to be $1.33 Million
Adjusted EPS is expected to be -$0.46

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.